Global

  1. Global—English
  2. 中国—简体中文

Investor Relations

Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.

HOME / Investor Relations / Financials
Corporate Governance Stock Information Disclosure Financials Presentations and Events Analyst Coverage Contact IR
All 2024 2023 2022 2021

  1. INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2022

  2. ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2021

Follow
Harbour BioMed
on WeChat

Copyright © 2024 Harbour BioMed. All Rights Reserved
沪公网安备31011502401396号 沪ICP备19015946号-1

FAMILY SITE

中文
ENG